The Patent Finder
US

Hydroxymethyl Substituted RNA Oligonucleotides and RNA Complexes

US 8,314,227 In force
OverviewFamilyAssignmentsSources & methods

Term ends Sep 19, 2028 · High confidence

Filed May 18, 2009 as application 12/515,403 · Granted Nov 20, 2012
Base term plus 121 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2008 2028
Clock starts
May 21, 2008
Term ends
Sep 19, 2028
Granted
Nov 20, 2012
base term patent term adjustment fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
121
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 121 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 21, 2008, when application PCT/US2008/064417, the earliest non-provisional in its chain, was filed (this one was filed May 18, 2009)May 21, 2028High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+121 days, USPTO patent term adjustment recordSep 19, 2028High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderSep 19, 2028High confidence

This family

US 8,314,227this patent
Sep 2028
Sep 2028
US 9,051,570In force
Sep 2028
Sep 2028
US 9,303,260In force
May 2028
May 2028
US 9,297,009In force
May 2028
May 2028
US 9,944,929Lapsed on the fee record
Apr 2026
Apr 2026
US 10,457,945In force
May 2028
May 2028
6 of 7 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 19, 2009
Reel 22704, frame 848
Wengel, JesperRibotask APSAssignment of Assignor's Interest
May 19, 2009
Reel 22704, frame 988
Ribotask APSMdrna, Inc.Assignment of Assignor's Interest
Dec 29, 2009
Reel 23708, frame 389
Mdrna, Inc.; Mdrna Research, Inc.; Nastech Pharmaceutical Company, Inc.Eos Holdings LLC, as AgentSecurity Agreement
Feb 23, 2010
Reel 23973, frame 286
Eos Holdings LLC, as AgentMdrna, Inc.; Mdrna Research, Inc.; Nastech Pharmaceutical Company, Inc.Release of Security Interest
Feb 23, 2010
reel/frame not recorded
Eos Holdings LLC, as AgentMdrna, Inc.Release of Security Interest
Feb 23, 2010
reel/frame not recorded
Eos Holdings LLC, as AgentMdrna Research, Inc.Release of Security Interest
Feb 23, 2010
reel/frame not recorded
Eos Holdings LLC, as AgentNastech Pharmaceutical Company, Inc.Release of Security Interest
Apr 28, 2010
Reel 24300, frame 825
Mdrna, Inc. FKA Nastech Pharmaceutical Company Inc.Cequent Pharmaceuticals, Inc.Security Agreement (PATENTS)
Jul 30, 2010
Reel 24767, frame 466
Cequent Pharmaceuticals, Inc.Marina Biotech, Inc. (F/K/A Mdrna, Inc.)Release of Security Interest
Nov 20, 2010
Reel 25411, frame 379
Mdrna, Inc.Marina Biotech, Inc.Change of Name
Feb 15, 2012
Reel 27712, frame 200
Marina Biotech, Inc.; Cequent Pharmaceuticals, Inc.; Mdrna Research, Inc.Genesis Capital Management, LLC, as AgentSecurity Agreement
May 13, 2013
Reel 30401, frame 461
Marina Biotech, Inc.; Cequent Pharmaceuticals, Inc.; Mdrna Research, Inc.Monsanto CompanySecurity Agreement
Aug 19, 2013
Reel 31039, frame 193
Marina Biotech, Inc.Arcturus Therapeutics, Inc.Assignment of Assignor's Interest
Apr 14, 2014
Reel 32685, frame 158
Genesis Capital Management, LLC, as AgentMarina Biotech, Inc.; Cequent Pharmaceuticals, Inc.; Mdrna Research, Inc.Release of Security Interest
Apr 14, 2014
reel/frame not recorded
Genesis Capital Management, LLC, as AgentMarina Biotech, Inc.Release of Security Interest
Apr 14, 2014
reel/frame not recorded
Genesis Capital Management, LLC, as AgentCequent Pharmaceuticals, Inc.Release of Security Interest
Apr 14, 2014
reel/frame not recorded
Genesis Capital Management, LLC, as AgentMdrna Research, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited